New knee injection shows promise for arthritis pain relief
Symptom relief
Completed
This early-stage study tested the safety of an experimental drug called CYT-108 for people with mild to moderate knee osteoarthritis. Nineteen participants received either the drug or a placebo injection into the knee, and researchers monitored them for 26 weeks. The goal was to …
Phase: PHASE1 • Sponsor: Cytonics Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC